DENTSPLY SIRONA Inc. XRAY Financial Statement Data


2025 Q2

Submissions

Field Row 1
adsh 0000818479-25-000056
cik 818479
name DENTSPLY SIRONA INC.
sic 3843
countryba US
stprba NC
cityba CHARLOTTE
zipba 28277-3607
bas1 13320 BALLANTYNE CORPORATE PLACE
bas2
baph 844-546-3722
countryma US
stprma NC
cityma CHARLOTTE
zipma 28277-3607
mas1 13320 BALLANTYNE CORPORATE PLACE
mas2
countryinc US
stprinc DE
ein 391434669
former DENTSPLY INTERNATIONAL INC /DE/
changed 19930630
afs 1-LAF
wksi 0
fye 1231
form 10-Q
period 20250331
fy 2025
fp Q1
filed 20250508
accepted 2025-05-08 09:14:00.0
prevrpt 0
detail 1
instance xray-20250331_htm.xml
nciks 1
aciks

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
cik Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings.
name Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date.
sic Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business.
countryba The ISO 3166-1 country of the registrant's business address.
stprba The state or province of the registrant’s business address, if field countryba is US or CA.
cityba The city of the registrant's business address.
zipba The zip code of the registrant’s business address.
bas1 The first line of the street of the registrant’s business address.
bas2 The second line of the street of the registrant’s business address.
baph The phone number of the registrant’s business address.
countryma The ISO 3166-1 country of the registrant's mailing address.
stprma The state or province of the registrant’s mailing address, if field countryma is US or CA.
cityma The city of the registrant's mailing address.
zipma The zip code of the registrant’s mailing address.
mas1 The first line of the street of the registrant’s mailing address.
mas2 The second line of the street of the registrant’s mailing address.
countryinc The ISO 3166-1 country of incorporation for the registrant.
stprinc The state or province of incorporation for the registrant, if countryinc is US or CA.
ein Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States.
former Most recent former name of the registrant, if any.
changed Date of change from the former name, if any.
afs Filer status with the SEC at the time of submission:
1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned.
wksi Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement.
fye Fiscal Year End Date, rounded to nearest month-end.
form The submission type of the registrant’s filing.
period Balance Sheet Date, rounded to nearest month-end.
fy Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8).
fp Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year.
filed The date of the registrant’s filing with the Commission.
accepted The acceptance date and time of the registrant’s filing with the Commission.
prevrpt Previous Report – TRUE indicates that the submission information was subsequently amended.
detail TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount).
instance The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol.
nciks Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing.
aciks Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information.

Numbers

adsh ddate tag value uom qtrs version segments coreg footnote
0000818479-25-000056 20241231 Additional Paid In Capital 6640000000.0000 USD 0 us-gaap/2024
0000818479-25-000056 20241231 Accumulated Other Comprehensive Income Loss Net Of Tax -730000000.0000 USD 0 us-gaap/2024
0000818479-25-000056 20240331 Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition 3000000.0000 USD 1 us-gaap/2024 Equity Components= Treasury Stock Common;
0000818479-25-000056 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 11000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 11000000.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0000818479-25-000056 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 10000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20250331 Amortization Of Intangible Assets 45000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20250331 Cash And Cash Equivalents At Carrying Value 398000000.0000 USD 0 us-gaap/2024
0000818479-25-000056 20241231 Common Stock Shares Issued 264500000.0000 shares 0 us-gaap/2024
0000818479-25-000056 20250331 Debt Current 33000000.0000 USD 0 us-gaap/2024 Short Term Debt Type= Uncommitted Short Term Financing;
0000818479-25-000056 20250331 Deferred Income Tax Liabilities Net 134000000.0000 USD 0 us-gaap/2024
0000818479-25-000056 20240331 Fair Value Of Assets Acquired 0.0000 USD 1 us-gaap/2024
0000818479-25-000056 20241231 Goodwill 503000000.0000 USD 0 us-gaap/2024 Business Segments= Orthodontic And Implant Solutions;
0000818479-25-000056 20250331 Goodwill 839000000.0000 USD 0 us-gaap/2024 Business Segments= Essential Dental Solutions;
0000818479-25-000056 20240331 Increase Decrease In Accounts And Notes Receivable -27000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20250331 Increase Decrease In Accrued Income Taxes Payable -12000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20240331 Increase Decrease In Other Noncurrent Liabilities -13000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20250331 Net Cash Provided By Used In Financing Activities 123000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20250331 Net Income Loss Attributable To Noncontrolling Interest -1000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20250331 Operating Income Loss 37000000.0000 USD 1 us-gaap/2024 Business Segments= Orthodontic And Implant Solutions; Consolidation Items= Operating Segments;
0000818479-25-000056 20241231 Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax -16000000.0000 USD 4 us-gaap/2024 Derivative Instrument Risk= Treasury Lock; Derivative Instruments Gain Loss By Hedging Relationship= Cash Flow Hedging;
0000818479-25-000056 20240331 Other Comprehensive Income Loss Net Of Tax -30000000.0000 USD 1 us-gaap/2024 Equity Components= Parent;
0000818479-25-000056 20250331 Preferred Stock Shares Issued 0.0000 shares 0 us-gaap/2024
0000818479-25-000056 20241231 Prepaid Expense And Other Assets Current 354000000.0000 USD 0 us-gaap/2024
0000818479-25-000056 20240331 Proceeds From Other Short Term Debt 0.0000 USD 1 us-gaap/2024
0000818479-25-000056 20240331 Profit Loss 18000000.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0000818479-25-000056 20250331 Profit Loss 20000000.0000 USD 1 us-gaap/2024 Equity Components= Parent;
0000818479-25-000056 20250331 Restructuring Charges 9000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20250331 Restructuring Charges 0.0000 USD 1 us-gaap/2024 Restructuring Cost And Reserve= Other Restructuring; Restructuring Plan= Other Restructuring Actions;
0000818479-25-000056 20240331 Revenue From Contract With Customer Excluding Assessed Tax 376000000.0000 USD 1 us-gaap/2024 Geographical= Europe;
0000818479-25-000056 20250331 Revenue From Contract With Customer Excluding Assessed Tax 134000000.0000 USD 1 us-gaap/2024 Business Segments= Connected Technology Solutions; Product Or Service= Equipment And Instruments;
0000818479-25-000056 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -473000000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Translation Adjustment;
0000818479-25-000056 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -31000000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Defined Benefit Plans Adjustment;
0000818479-25-000056 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -67000000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Foreign Currency Adjustment Including Portion Attributable To Noncontrolling Interest Net Investment Hedges;
0000818479-25-000056 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -619000000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Translation Adjustment;
0000818479-25-000056 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 6631000000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0000818479-25-000056 20250331 Accrued Income Taxes Current 37000000.0000 USD 0 us-gaap/2024
0000818479-25-000056 20241231 Accrued Liabilities Current 754000000.0000 USD 0 us-gaap/2024
0000818479-25-000056 20250331 Additional Paid In Capital 6631000000.0000 USD 0 us-gaap/2024
0000818479-25-000056 20250331 Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition 2000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20240331 Amortization Of Intangible Assets 54000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20250331 Capital Expenditures Incurred But Not Yet Paid 22000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20250331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect 126000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20250331 Common Stock Dividends Per Share Declared 0.1600 USD 1 us-gaap/2024
0000818479-25-000056 20250331 Common Stock Shares Issued 264500000.0000 shares 0 us-gaap/2024
0000818479-25-000056 20250331 Common Stock Value 3000000.0000 USD 0 us-gaap/2024
0000818479-25-000056 20240331 Comprehensive Income Net Of Tax -12000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20241231 Deferred Income Tax Liabilities Net 129000000.0000 USD 0 us-gaap/2024
0000818479-25-000056 20240331 Dividends Cash 33000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20250331 Dividends Cash 32000000.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0000818479-25-000056 20250331 Earnings Per Share Diluted 0.1000 USD 1 us-gaap/2024
0000818479-25-000056 20250331 Goodwill 1632000000.0000 USD 0 us-gaap/2024
0000818479-25-000056 20240331 Impairment Of Intangible Assets Indefinitelived Excluding Goodwill 6000000.0000 USD 1 us-gaap/2024 Business Segments= Connected Technology Solutions; Finite Lived Intangible Assets By Major Class= Trade Names;
0000818479-25-000056 20250331 Impairment Of Intangible Assets Indefinitelived Excluding Goodwill 0.0000 USD 1 us-gaap/2024
0000818479-25-000056 20250331 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest 44000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20250331 Increase Decrease In Other Noncurrent Assets -4000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20250331 Increase Decrease In Other Noncurrent Liabilities -15000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20240331 Increase Decrease In Prepaid Deferred Expense And Other Assets 28000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20240331 Interest Expense Nonoperating 18000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20240331 Interest Expense Nonoperating 18000000.0000 USD 1 us-gaap/2024 Consolidation Items= Material Reconciling Items;
0000818479-25-000056 20250331 Interest Expense Nonoperating 19000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20250331 Inventory Net 612000000.0000 USD 0 us-gaap/2024
0000818479-25-000056 20250331 Long Term Debt Noncurrent 1593000000.0000 USD 0 us-gaap/2024
0000818479-25-000056 20240331 Net Income Loss 18000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20240331 Operating Income Loss 42000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20240331 Operating Income Loss 182000000.0000 USD 1 us-gaap/2024 Consolidation Items= Operating Segments;
0000818479-25-000056 20250331 Operating Income Loss 63000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20250331 Operating Income Loss 7000000.0000 USD 1 us-gaap/2024 Business Segments= Connected Technology Solutions; Consolidation Items= Operating Segments;
0000818479-25-000056 20250331 Operating Lease Liability Noncurrent 88000000.0000 USD 0 us-gaap/2024
0000818479-25-000056 20241231 Operating Lease Right Of Use Asset 136000000.0000 USD 0 us-gaap/2024
0000818479-25-000056 20250331 Operating Lease Right Of Use Asset 133000000.0000 USD 0 us-gaap/2024
0000818479-25-000056 20241231 Other Assets Noncurrent 301000000.0000 USD 0 us-gaap/2024
0000818479-25-000056 20240331 Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax 32000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20240331 Payments For Hedge Investing Activities 9000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20250331 Proceeds From Sale Of Property Plant And Equipment 1000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20240331 Profit Loss 18000000.0000 USD 1 us-gaap/2024 Equity Components= Parent;
0000818479-25-000056 20250331 Profit Loss -1000000.0000 USD 1 us-gaap/2024 Equity Components= Noncontrolling Interest;
0000818479-25-000056 20250331 Repayments Of Long Term Debt 2000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20240331 Revenue From Contract With Customer Excluding Assessed Tax 122000000.0000 USD 1 us-gaap/2024 Business Segments= Connected Technology Solutions; Product Or Service= C A D C A M;
0000818479-25-000056 20240331 Revenue From Contract With Customer Excluding Assessed Tax 953000000.0000 USD 1 us-gaap/2024 Consolidation Items= Operating Segments;
0000818479-25-000056 20250331 Revenue From Contract With Customer Excluding Assessed Tax 158000000.0000 USD 1 us-gaap/2024 Business Segments= Orthodontic And Implant Solutions; Product Or Service= Implants And Prosthetics;
0000818479-25-000056 20250331 Revenue From Contract With Customer Excluding Assessed Tax 362000000.0000 USD 1 us-gaap/2024 Geographical= Europe;
0000818479-25-000056 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -13000000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Gain Loss Net Cash Flow Hedge Parent;
0000818479-25-000056 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -535000000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Translation Adjustment;
0000818479-25-000056 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 3258000000.0000 USD 0 us-gaap/2024 Equity Components= Parent;
0000818479-25-000056 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 1942000000.0000 USD 0 us-gaap/2024 Equity Components= Parent;
0000818479-25-000056 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -31000000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Defined Benefit Plans Adjustment;
0000818479-25-000056 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 2010000000.0000 USD 0 us-gaap/2024 Equity Components= Parent;
0000818479-25-000056 20240331 Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures -4000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20241231 Treasury Stock Common Shares 65700000.0000 shares 0 us-gaap/2024
0000818479-25-000056 20240331 Weighted Average Number Of Shares Outstanding Basic 207400000.0000 shares 1 us-gaap/2024
0000818479-25-000056 20240331 Profit Loss 17000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 10000000.0000 USD 1 us-gaap/2024 Equity Components= Parent;
0000818479-25-000056 20250331 Amortization Of Intangible Assets 45000000.0000 USD 1 us-gaap/2024 Consolidation Items= Material Reconciling Items;
0000818479-25-000056 20241231 Assets 5753000000.0000 USD 0 us-gaap/2024
0000818479-25-000056 20250331 Commitments And Contingencies USD 0 us-gaap/2024
0000818479-25-000056 20250331 Cost Of Goods And Services Sold 413000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20241231 Debt Current 549000000.0000 USD 0 us-gaap/2024
0000818479-25-000056 20250331 Debt Current 742000000.0000 USD 0 us-gaap/2024
0000818479-25-000056 20250331 Debt Current 9000000.0000 USD 0 us-gaap/2024 Short Term Debt Type= Other Short Term Loans;
0000818479-25-000056 20240331 Deferred Income Tax Expense Benefit -9000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20250331 Depreciation 34000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20240331 Dividends Cash 33000000.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0000818479-25-000056 20250331 Dividends Share Based Compensation Cash 0.0000 USD 1 us-gaap/2024
0000818479-25-000056 20240331 Earnings Per Share Basic 0.0900 USD 1 us-gaap/2024
0000818479-25-000056 20241231 Goodwill 265000000.0000 USD 0 us-gaap/2024 Business Segments= Wellspect Healthcare;
0000818479-25-000056 20240331 Gross Profit 506000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20250331 Gross Profit 466000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20240331 Increase Decrease In Accounts Payable -28000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20240331 Interest Paid Net 15000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20241231 Inventory Net 564000000.0000 USD 0 us-gaap/2024
0000818479-25-000056 20240331 Net Cash Provided By Used In Financing Activities -14000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20250331 Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax -16000000.0000 USD 1 us-gaap/2024 Derivative Instrument Risk= Treasury Lock; Derivative Instruments Gain Loss By Hedging Relationship= Cash Flow Hedging;
0000818479-25-000056 20240331 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax -62000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20240331 Other Comprehensive Income Loss Net Of Tax -30000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20240331 Other Comprehensive Income Loss Net Of Tax 32000000.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Net Gain Loss From Derivatives Not Designated As Cash Flow Hedges Attributable To Parent;
0000818479-25-000056 20250331 Other Nonoperating Income Expense 0.0000 USD 1 us-gaap/2024
0000818479-25-000056 20250331 Payments Of Financing Costs 3000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20250331 Payments To Acquire Productive Assets 19000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20240331 Repayments Of Long Term Debt 3000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20240331 Research And Development Expense 42000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20250331 Restructuring Charges 0.0000 USD 1 us-gaap/2024 Restructuring Cost And Reserve= Other Restructuring;
0000818479-25-000056 20250331 Retained Earnings Accumulated Deficit -848000000.0000 USD 0 us-gaap/2024
0000818479-25-000056 20240331 Revenue From Contract With Customer Excluding Assessed Tax 71000000.0000 USD 1 us-gaap/2024 Business Segments= Wellspect Healthcare; Consolidation Items= Operating Segments;
0000818479-25-000056 20241231 Stockholders Equity 1942000000.0000 USD 0 us-gaap/2024
0000818479-25-000056 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -43000000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Defined Benefit Plans Adjustment;
0000818479-25-000056 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -636000000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0000818479-25-000056 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -2922000000.0000 USD 0 us-gaap/2024 Equity Components= Treasury Stock Common;
0000818479-25-000056 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 3258000000.0000 USD 0 us-gaap/2024
0000818479-25-000056 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -13000000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Gain Loss Net Cash Flow Hedge Parent;
0000818479-25-000056 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -75000000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Net Gain Loss From Derivatives Not Designated As Cash Flow Hedges Attributable To Parent;
0000818479-25-000056 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -666000000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0000818479-25-000056 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 6640000000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0000818479-25-000056 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 3000000.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0000818479-25-000056 20240331 Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures -15000000.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0000818479-25-000056 20250331 Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures -3000000.0000 USD 1 us-gaap/2024 Equity Components= Parent;
0000818479-25-000056 20241231 Treasury Stock Common Value 3136000000.0000 USD 0 us-gaap/2024
0000818479-25-000056 20250331 Weighted Average Number Of Shares Outstanding Basic 199100000.0000 shares 1 us-gaap/2024
0000818479-25-000056 20241231 Accounts Notes And Loans Receivable Net Current 556000000.0000 USD 0 us-gaap/2024
0000818479-25-000056 20250331 Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition 2000000.0000 USD 1 us-gaap/2024 Equity Components= Parent;
0000818479-25-000056 20250331 Assets Current 1978000000.0000 USD 0 us-gaap/2024
0000818479-25-000056 20241231 Commitments And Contingencies USD 0 us-gaap/2024
0000818479-25-000056 20241231 Common Stock Par Or Stated Value Per Share 0.0100 USD 0 us-gaap/2024
0000818479-25-000056 20250331 Comprehensive Income Net Of Tax 91000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20240331 Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest -13000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20241231 Debt Current 0.0000 USD 0 us-gaap/2024 Credit Facility= Revolving Credit Facility; Longterm Debt Type= Line Of Credit;
0000818479-25-000056 20250331 Deferred Income Tax Expense Benefit 1000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20240331 Depreciation 32000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20250331 Dividends Share Based Compensation Cash -1000000.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0000818479-25-000056 20250331 Fair Value Of Assets Acquired 14000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20240331 Impairment Of Intangible Assets Indefinitelived Excluding Goodwill 6000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20240331 Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest 31000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20240331 Increase Decrease In Accrued Liabilities -50000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20250331 Increase Decrease In Accrued Liabilities -44000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20240331 Increase Decrease In Inventories 5000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20250331 Increase Decrease In Inventories 26000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20250331 Increase Decrease In Prepaid Deferred Expense And Other Assets 1000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20241231 Long Term Debt Noncurrent 1586000000.0000 USD 0 us-gaap/2024
0000818479-25-000056 20241231 Minority Interest 1000000.0000 USD 0 us-gaap/2024
0000818479-25-000056 20250331 Minority Interest 0.0000 USD 0 us-gaap/2024
0000818479-25-000056 20250331 Net Income Loss 20000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20250331 Operating Income Loss 135000000.0000 USD 1 us-gaap/2024 Business Segments= Essential Dental Solutions; Consolidation Items= Operating Segments;
0000818479-25-000056 20250331 Other Comprehensive Income Loss Net Of Tax 0.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Defined Benefit Plans Adjustment;
0000818479-25-000056 20250331 Preferred Stock Value 0.0000 USD 0 us-gaap/2024
0000818479-25-000056 20250331 Profit Loss 19000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20250331 Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization 791000000.0000 USD 0 us-gaap/2024
0000818479-25-000056 20250331 Restructuring Charges 9000000.0000 USD 1 us-gaap/2024 Consolidation Items= Material Reconciling Items;
0000818479-25-000056 20250331 Restructuring Charges 6000000.0000 USD 1 us-gaap/2024 Restructuring Cost And Reserve= Employee Severance; Restructuring Plan= Other Restructuring Actions;
0000818479-25-000056 20250331 Restructuring Charges 0.0000 USD 1 us-gaap/2024 Restructuring Cost And Reserve= Employee Severance; Restructuring Plan= Restructuring Fiscal2023 And Prior Plans;
0000818479-25-000056 20250331 Restructuring Charges 0.0000 USD 1 us-gaap/2024 Restructuring Cost And Reserve= Other Restructuring; Restructuring Plan= Restructuring Fiscal2024 Plan;
0000818479-25-000056 20240331 Revenue From Contract With Customer Excluding Assessed Tax 247000000.0000 USD 1 us-gaap/2024 Business Segments= Connected Technology Solutions;
0000818479-25-000056 20240331 Revenue From Contract With Customer Excluding Assessed Tax 221000000.0000 USD 1 us-gaap/2024 Geographical= Rest Of The World;
0000818479-25-000056 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 3000000.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0000818479-25-000056 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 0.0000 USD 0 us-gaap/2024 Equity Components= Noncontrolling Interest;
0000818479-25-000056 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 2010000000.0000 USD 0 us-gaap/2024
0000818479-25-000056 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -443000000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Foreign Currency Adjustment Including Portion Attributable To Noncontrolling Interest Translation Gain Loss;
0000818479-25-000056 20250331 Accumulated Other Comprehensive Income Loss Net Of Tax -659000000.0000 USD 0 us-gaap/2024
0000818479-25-000056 20240331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 11000000.0000 USD 1 us-gaap/2024 Equity Components= Parent;
0000818479-25-000056 20250331 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 10000000.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0000818479-25-000056 20240331 Amortization Of Intangible Assets 54000000.0000 USD 1 us-gaap/2024 Consolidation Items= Material Reconciling Items;
0000818479-25-000056 20241231 Cash And Cash Equivalents At Carrying Value 272000000.0000 USD 0 us-gaap/2024
0000818479-25-000056 20240331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect -43000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20250331 Common Stock Shares Authorized 400000000.0000 shares 0 us-gaap/2024
0000818479-25-000056 20240331 Cost Of Goods And Services Sold 447000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20241231 Debt Current 410000000.0000 USD 0 us-gaap/2024 Credit Facility= Commercial Paper; Longterm Debt Type= Line Of Credit;
0000818479-25-000056 20250331 Dividends Cash 32000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20250331 Dividends Share Based Compensation Cash 1000000.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0000818479-25-000056 20241231 Goodwill 1597000000.0000 USD 0 us-gaap/2024
0000818479-25-000056 20250331 Goodwill 522000000.0000 USD 0 us-gaap/2024 Business Segments= Orthodontic And Implant Solutions;
0000818479-25-000056 20250331 Increase Decrease In Accounts Payable 14000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20240331 Increase Decrease In Accrued Income Taxes Payable -2000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20241231 Intangible Assets Net Excluding Goodwill 1207000000.0000 USD 0 us-gaap/2024
0000818479-25-000056 20250331 Interest Expense Nonoperating 19000000.0000 USD 1 us-gaap/2024 Consolidation Items= Material Reconciling Items;
0000818479-25-000056 20250331 Interest Paid Net 13000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20241231 Liabilities And Stockholders Equity 5753000000.0000 USD 0 us-gaap/2024
0000818479-25-000056 20250331 Liabilities And Stockholders Equity 6050000000.0000 USD 0 us-gaap/2024
0000818479-25-000056 20250331 Liabilities Current 1793000000.0000 USD 0 us-gaap/2024
0000818479-25-000056 20240331 Net Cash Provided By Used In Investing Activities -43000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20240331 Operating Income Loss 23000000.0000 USD 1 us-gaap/2024 Business Segments= Wellspect Healthcare; Consolidation Items= Operating Segments;
0000818479-25-000056 20250331 Operating Income Loss 205000000.0000 USD 1 us-gaap/2024 Consolidation Items= Operating Segments;
0000818479-25-000056 20241231 Operating Lease Liability Noncurrent 91000000.0000 USD 0 us-gaap/2024
0000818479-25-000056 20240331 Other Comprehensive Income Loss Net Of Tax 0.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Defined Benefit Plans Adjustment;
0000818479-25-000056 20240331 Other Comprehensive Income Loss Net Of Tax -62000000.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Translation Adjustment;
0000818479-25-000056 20250331 Other Comprehensive Income Loss Net Of Tax 71000000.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0000818479-25-000056 20241231 Other Liabilities Noncurrent 415000000.0000 USD 0 us-gaap/2024
0000818479-25-000056 20250331 Other Liabilities Noncurrent 432000000.0000 USD 0 us-gaap/2024
0000818479-25-000056 20250331 Other Noncash Income Expense -9000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20241231 Preferred Stock Shares Authorized 250000.0000 shares 0 us-gaap/2024
0000818479-25-000056 20250331 Prepaid Expense And Other Assets Current 364000000.0000 USD 0 us-gaap/2024
0000818479-25-000056 20240331 Proceeds From Derivative Instrument Investing Activities 0.0000 USD 1 us-gaap/2024
0000818479-25-000056 20250331 Proceeds From Payments For Other Financing Activities -3000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20250331 Restructuring Charges 8000000.0000 USD 1 us-gaap/2024 Restructuring Cost And Reserve= Employee Severance;
0000818479-25-000056 20240331 Revenue From Contract With Customer Excluding Assessed Tax 271000000.0000 USD 1 us-gaap/2024 Business Segments= Orthodontic And Implant Solutions;
0000818479-25-000056 20240331 Revenue From Contract With Customer Excluding Assessed Tax 98000000.0000 USD 1 us-gaap/2024 Business Segments= Orthodontic And Implant Solutions; Product Or Service= Orthodontics;
0000818479-25-000056 20250331 Revenue From Contract With Customer Excluding Assessed Tax 879000000.0000 USD 1 us-gaap/2024 Consolidation Items= Operating Segments;
0000818479-25-000056 20240331 Selling General And Administrative Expense 415000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20250331 Stockholders Equity 2010000000.0000 USD 0 us-gaap/2024
0000818479-25-000056 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -107000000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Net Gain Loss From Derivatives Not Designated As Cash Flow Hedges Attributable To Parent;
0000818479-25-000056 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 3000000.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0000818479-25-000056 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 205000000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0000818479-25-000056 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -2908000000.0000 USD 0 us-gaap/2024 Equity Components= Treasury Stock Common;
0000818479-25-000056 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 1943000000.0000 USD 0 us-gaap/2024
0000818479-25-000056 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -730000000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0000818479-25-000056 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -89000000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Foreign Currency Adjustment Including Portion Attributable To Noncontrolling Interest Net Investment Hedges;
0000818479-25-000056 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -10000000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Gain Loss Net Cash Flow Hedge Parent;
0000818479-25-000056 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -86000000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Net Gain Loss From Derivatives Not Designated As Cash Flow Hedges Attributable To Parent;
0000818479-25-000056 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 3000000.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0000818479-25-000056 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 0.0000 USD 0 us-gaap/2024 Equity Components= Noncontrolling Interest;
0000818479-25-000056 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -3117000000.0000 USD 0 us-gaap/2024 Equity Components= Treasury Stock Common;
0000818479-25-000056 20250331 Accounts Notes And Loans Receivable Net Current 604000000.0000 USD 0 us-gaap/2024
0000818479-25-000056 20250331 Accrued Liabilities Current 738000000.0000 USD 0 us-gaap/2024
0000818479-25-000056 20250331 Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition -3000000.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0000818479-25-000056 20250331 Assets 6050000000.0000 USD 0 us-gaap/2024
0000818479-25-000056 20231231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 334000000.0000 USD 0 us-gaap/2024
0000818479-25-000056 20240331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 291000000.0000 USD 0 us-gaap/2024
0000818479-25-000056 20241231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 272000000.0000 USD 0 us-gaap/2024
0000818479-25-000056 20250331 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 398000000.0000 USD 0 us-gaap/2024
0000818479-25-000056 20240331 Common Stock Dividends Per Share Declared 0.1400 USD 1 us-gaap/2024
0000818479-25-000056 20250331 Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest -1000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20250331 Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest 90000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20250331 Debt Current 140000000.0000 USD 0 us-gaap/2024 Credit Facility= Commercial Paper; Longterm Debt Type= Line Of Credit;
0000818479-25-000056 20240331 Dividends Cash 33000000.0000 USD 1 us-gaap/2024 Equity Components= Parent;
0000818479-25-000056 20250331 Dividends Share Based Compensation Cash 0.0000 USD 1 us-gaap/2024 Equity Components= Parent;
0000818479-25-000056 20240331 Earnings Per Share Diluted 0.0900 USD 1 us-gaap/2024
0000818479-25-000056 20241231 Goodwill 0.0000 USD 0 us-gaap/2024 Business Segments= Connected Technology Solutions;
0000818479-25-000056 20250331 Income Tax Expense Benefit 25000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20240331 Increase Decrease In Other Noncurrent Assets 6000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20250331 Intangible Assets Net Excluding Goodwill 1212000000.0000 USD 0 us-gaap/2024
0000818479-25-000056 20250331 Net Cash Provided By Used In Operating Activities 7000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20240331 Net Income Loss Attributable To Noncontrolling Interest -1000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20240331 Other Comprehensive Income Loss Net Of Tax 0.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Gain Loss Net Cash Flow Hedge Parent;
0000818479-25-000056 20250331 Other Comprehensive Income Loss Net Of Tax 87000000.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Translation Adjustment;
0000818479-25-000056 20240331 Other Noncash Income Expense -19000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20250331 Payments Of Dividends 32000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20250331 Preferred Stock Par Or Stated Value Per Share 1.0000 USD 0 us-gaap/2024
0000818479-25-000056 20241231 Preferred Stock Shares Issued 0.0000 shares 0 us-gaap/2024
0000818479-25-000056 20241231 Preferred Stock Value 0.0000 USD 0 us-gaap/2024
0000818479-25-000056 20250331 Proceeds From Repayments Of Short Term Debt Maturing In More Than Three Months -272000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20240331 Proceeds From Sale Of Property Plant And Equipment 0.0000 USD 1 us-gaap/2024
0000818479-25-000056 20250331 Profit Loss 20000000.0000 USD 1 us-gaap/2024 Equity Components= Retained Earnings;
0000818479-25-000056 20241231 Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization 766000000.0000 USD 0 us-gaap/2024
0000818479-25-000056 20250331 Restructuring Charges 0.0000 USD 1 us-gaap/2024 Restructuring Cost And Reserve= Other Restructuring; Restructuring Plan= Restructuring Fiscal2023 And Prior Plans;
0000818479-25-000056 20240331 Revenue From Contract With Customer Excluding Assessed Tax 247000000.0000 USD 1 us-gaap/2024 Business Segments= Connected Technology Solutions; Consolidation Items= Operating Segments;
0000818479-25-000056 20240331 Revenue From Contract With Customer Excluding Assessed Tax 271000000.0000 USD 1 us-gaap/2024 Business Segments= Orthodontic And Implant Solutions; Consolidation Items= Operating Segments;
0000818479-25-000056 20240331 Revenue From Contract With Customer Excluding Assessed Tax 356000000.0000 USD 1 us-gaap/2024 Geographical= U S;
0000818479-25-000056 20250331 Revenue From Contract With Customer Excluding Assessed Tax 235000000.0000 USD 1 us-gaap/2024 Business Segments= Connected Technology Solutions; Consolidation Items= Operating Segments;
0000818479-25-000056 20250331 Treasury Stock Common Value 3117000000.0000 USD 0 us-gaap/2024
0000818479-25-000056 20250331 Revenue From Contract With Customer Excluding Assessed Tax 101000000.0000 USD 1 us-gaap/2024 Business Segments= Connected Technology Solutions; Product Or Service= C A D C A M;
0000818479-25-000056 20250331 Revenue From Contract With Customer Excluding Assessed Tax 217000000.0000 USD 1 us-gaap/2024 Business Segments= Orthodontic And Implant Solutions; Consolidation Items= Operating Segments;
0000818479-25-000056 20240331 Share Based Compensation 11000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 3294000000.0000 USD 0 us-gaap/2024
0000818479-25-000056 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 6643000000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0000818479-25-000056 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 1000000.0000 USD 0 us-gaap/2024 Equity Components= Noncontrolling Interest;
0000818479-25-000056 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -43000000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Defined Benefit Plans Adjustment;
0000818479-25-000056 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 190000000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0000818479-25-000056 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 1000000.0000 USD 0 us-gaap/2024 Equity Components= Noncontrolling Interest;
0000818479-25-000056 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -835000000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0000818479-25-000056 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -659000000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0000818479-25-000056 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -532000000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Translation Adjustment;
0000818479-25-000056 20250331 Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures -3000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20250331 Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures -17000000.0000 USD 1 us-gaap/2024 Equity Components= Additional Paid In Capital;
0000818479-25-000056 20241231 Liabilities 3810000000.0000 USD 0 us-gaap/2024
0000818479-25-000056 20241231 Accounts Payable Current 241000000.0000 USD 0 us-gaap/2024
0000818479-25-000056 20250331 Accounts Payable Current 276000000.0000 USD 0 us-gaap/2024
0000818479-25-000056 20240331 Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition 3000000.0000 USD 1 us-gaap/2024 Equity Components= Parent;
0000818479-25-000056 20250331 Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition 5000000.0000 USD 1 us-gaap/2024 Equity Components= Treasury Stock Common;
0000818479-25-000056 20241231 Assets Current 1746000000.0000 USD 0 us-gaap/2024
0000818479-25-000056 20241231 Common Stock Shares Authorized 400000000.0000 shares 0 us-gaap/2024
0000818479-25-000056 20241231 Common Stock Value 3000000.0000 USD 0 us-gaap/2024
0000818479-25-000056 20250331 Debt Current 0.0000 USD 0 us-gaap/2024 Credit Facility= Revolving Credit Facility; Longterm Debt Type= Line Of Credit;
0000818479-25-000056 20240331 Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents -11000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20250331 Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 13000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20241231 Goodwill 829000000.0000 USD 0 us-gaap/2024 Business Segments= Essential Dental Solutions;
0000818479-25-000056 20250331 Goodwill 0.0000 USD 0 us-gaap/2024 Business Segments= Connected Technology Solutions;
0000818479-25-000056 20250331 Goodwill 271000000.0000 USD 0 us-gaap/2024 Business Segments= Wellspect Healthcare;
0000818479-25-000056 20250331 Increase Decrease In Accounts And Notes Receivable 31000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20240331 Operating Income Loss 2000000.0000 USD 1 us-gaap/2024 Business Segments= Connected Technology Solutions; Consolidation Items= Operating Segments;
0000818479-25-000056 20240331 Operating Income Loss 42000000.0000 USD 1 us-gaap/2024 Business Segments= Orthodontic And Implant Solutions; Consolidation Items= Operating Segments;
0000818479-25-000056 20250331 Operating Income Loss 26000000.0000 USD 1 us-gaap/2024 Business Segments= Wellspect Healthcare; Consolidation Items= Operating Segments;
0000818479-25-000056 20250331 Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax -16000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20250331 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax 87000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20250331 Other Comprehensive Income Loss Net Of Tax 71000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20240331 Other Nonoperating Income Expense 7000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20250331 Payments For Hedge Investing Activities 0.0000 USD 1 us-gaap/2024
0000818479-25-000056 20240331 Payments To Acquire Productive Assets 34000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20241231 Preferred Stock Par Or Stated Value Per Share 1.0000 USD 0 us-gaap/2024
0000818479-25-000056 20250331 Preferred Stock Shares Authorized 250000.0000 shares 0 us-gaap/2024
0000818479-25-000056 20250331 Proceeds From Derivative Instrument Investing Activities 1000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20240331 Proceeds From Repayments Of Short Term Debt Maturing In More Than Three Months 23000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20250331 Restructuring Charges 2000000.0000 USD 1 us-gaap/2024 Restructuring Cost And Reserve= Employee Severance; Restructuring Plan= Restructuring Fiscal2024 Plan;
0000818479-25-000056 20241231 Retained Earnings Accumulated Deficit -835000000.0000 USD 0 us-gaap/2024
0000818479-25-000056 20240331 Revenue From Contract With Customer Excluding Assessed Tax 125000000.0000 USD 1 us-gaap/2024 Business Segments= Connected Technology Solutions; Product Or Service= Equipment And Instruments;
0000818479-25-000056 20250331 Revenue From Contract With Customer Excluding Assessed Tax 879000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20250331 Revenue From Contract With Customer Excluding Assessed Tax 235000000.0000 USD 1 us-gaap/2024 Business Segments= Connected Technology Solutions;
0000818479-25-000056 20250331 Revenue From Contract With Customer Excluding Assessed Tax 353000000.0000 USD 1 us-gaap/2024 Business Segments= Essential Dental Solutions; Consolidation Items= Operating Segments;
0000818479-25-000056 20250331 Revenue From Contract With Customer Excluding Assessed Tax 217000000.0000 USD 1 us-gaap/2024 Business Segments= Orthodontic And Implant Solutions;
0000818479-25-000056 20250331 Selling General And Administrative Expense 358000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20250331 Share Based Compensation 10000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20240331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 6639000000.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0000818479-25-000056 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -552000000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Foreign Currency Adjustment Including Portion Attributable To Noncontrolling Interest Translation Gain Loss;
0000818479-25-000056 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -10000000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Gain Loss Net Cash Flow Hedge Parent;
0000818479-25-000056 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -70000000.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Net Gain Loss From Derivatives Not Designated As Cash Flow Hedges Attributable To Parent;
0000818479-25-000056 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -3136000000.0000 USD 0 us-gaap/2024 Equity Components= Treasury Stock Common;
0000818479-25-000056 20250331 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -848000000.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0000818479-25-000056 20240331 Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures -4000000.0000 USD 1 us-gaap/2024 Equity Components= Parent;
0000818479-25-000056 20250331 Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures 14000000.0000 USD 1 us-gaap/2024 Equity Components= Treasury Stock Common;
0000818479-25-000056 20250331 Weighted Average Number Of Diluted Shares Outstanding 199800000.0000 shares 1 us-gaap/2024
0000818479-25-000056 20240331 Payments Of Financing Costs 0.0000 USD 1 us-gaap/2024
0000818479-25-000056 20240331 Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest -1000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20250331 Dividends Cash 32000000.0000 USD 1 us-gaap/2024 Equity Components= Parent;
0000818479-25-000056 20250331 Earnings Per Share Basic 0.1000 USD 1 us-gaap/2024
0000818479-25-000056 20240331 Income Tax Expense Benefit 14000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20250331 Liabilities 4040000000.0000 USD 0 us-gaap/2024
0000818479-25-000056 20241231 Liabilities Current 1589000000.0000 USD 0 us-gaap/2024
0000818479-25-000056 20250331 Net Cash Provided By Used In Investing Activities -17000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20240331 Net Cash Provided By Used In Operating Activities 25000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20240331 Operating Income Loss 115000000.0000 USD 1 us-gaap/2024 Business Segments= Essential Dental Solutions; Consolidation Items= Operating Segments;
0000818479-25-000056 20250331 Other Assets Noncurrent 304000000.0000 USD 0 us-gaap/2024
0000818479-25-000056 20240331 Other Comprehensive Income Loss Net Of Tax -30000000.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0000818479-25-000056 20250331 Other Comprehensive Income Loss Net Of Tax 0.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Gain Loss Net Cash Flow Hedge Parent;
0000818479-25-000056 20250331 Other Comprehensive Income Loss Net Of Tax -16000000.0000 USD 1 us-gaap/2024 Equity Components= Accumulated Net Gain Loss From Derivatives Not Designated As Cash Flow Hedges Attributable To Parent;
0000818479-25-000056 20250331 Other Comprehensive Income Loss Net Of Tax 71000000.0000 USD 1 us-gaap/2024 Equity Components= Parent;
0000818479-25-000056 20240331 Other Nonoperating Income Expense 7000000.0000 USD 1 us-gaap/2024 Consolidation Items= Material Reconciling Items;
0000818479-25-000056 20240331 Payments Of Dividends 29000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20250331 Proceeds From Other Short Term Debt 435000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20240331 Proceeds From Payments For Other Financing Activities -5000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20240331 Profit Loss -1000000.0000 USD 1 us-gaap/2024 Equity Components= Noncontrolling Interest;
0000818479-25-000056 20250331 Research And Development Expense 36000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20240331 Restructuring Charges 1000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20240331 Restructuring Charges 1000000.0000 USD 1 us-gaap/2024 Consolidation Items= Material Reconciling Items;
0000818479-25-000056 20240331 Revenue From Contract With Customer Excluding Assessed Tax 953000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20240331 Revenue From Contract With Customer Excluding Assessed Tax 364000000.0000 USD 1 us-gaap/2024 Business Segments= Essential Dental Solutions; Consolidation Items= Operating Segments;
0000818479-25-000056 20240331 Revenue From Contract With Customer Excluding Assessed Tax 173000000.0000 USD 1 us-gaap/2024 Business Segments= Orthodontic And Implant Solutions; Product Or Service= Implants And Prosthetics;
0000818479-25-000056 20250331 Revenue From Contract With Customer Excluding Assessed Tax 59000000.0000 USD 1 us-gaap/2024 Business Segments= Orthodontic And Implant Solutions; Product Or Service= Orthodontics;
0000818479-25-000056 20250331 Revenue From Contract With Customer Excluding Assessed Tax 74000000.0000 USD 1 us-gaap/2024 Business Segments= Wellspect Healthcare; Consolidation Items= Operating Segments;
0000818479-25-000056 20250331 Revenue From Contract With Customer Excluding Assessed Tax 215000000.0000 USD 1 us-gaap/2024 Geographical= Rest Of The World;
0000818479-25-000056 20250331 Revenue From Contract With Customer Excluding Assessed Tax 302000000.0000 USD 1 us-gaap/2024 Geographical= U S;
0000818479-25-000056 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 3293000000.0000 USD 0 us-gaap/2024 Equity Components= Parent;
0000818479-25-000056 20240331 Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures 11000000.0000 USD 1 us-gaap/2024 Equity Components= Treasury Stock Common;
0000818479-25-000056 20250331 Treasury Stock Common Shares 65200000.0000 shares 0 us-gaap/2024
0000818479-25-000056 20240331 Weighted Average Number Of Diluted Shares Outstanding 208500000.0000 shares 1 us-gaap/2024
0000818479-25-000056 20241231 Accrued Income Taxes Current 45000000.0000 USD 0 us-gaap/2024
0000818479-25-000056 20240331 Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition 3000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20240331 Capital Expenditures Incurred But Not Yet Paid 24000000.0000 USD 1 us-gaap/2024
0000818479-25-000056 20250331 Common Stock Par Or Stated Value Per Share 0.0100 USD 0 us-gaap/2024
0000818479-25-000056 20241231 Common Stock Shares Outstanding 198800000.0000 shares 0 us-gaap/2024
0000818479-25-000056 20250331 Common Stock Shares Outstanding 199300000.0000 shares 0 us-gaap/2024

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
tag The unique identifier (name) for a tag in a specific taxonomy release.
version For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined.
ddate The end date for the data value, rounded to the nearest month end.
qtrs The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value.
uom The unit of measure for the value.
segments Tags used to represent axis and member reporting.
coreg If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity.
value The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point.
footnote The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank.

Tags

tag version custom abstract datatype iord crdr tlabel doc
Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest us-gaap/2024 0 0 monetary D C Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.
Assets Current us-gaap/2024 0 0 monetary I D Assets, Current Amount of asset recognized for present right to economic benefit, classified as current.
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 0 0 monetary I D Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Increase Decrease In Other Noncurrent Assets us-gaap/2024 0 0 monetary D C Increase (Decrease) in Other Noncurrent Assets Amount of increase (decrease) in noncurrent assets classified as other.
Revenue From Contract With Customer Excluding Assessed Tax us-gaap/2024 0 0 monetary D C Revenue from Contract with Customer, Excluding Assessed Tax Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
Dividends Share Based Compensation Cash us-gaap/2024 0 0 monetary D D Dividend, Share-Based Payment Arrangement, Cash Amount of paid and unpaid cash dividends declared for award under share-based payment arrangement.
Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax us-gaap/2024 0 0 monetary D C Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.
Stockholders Equity Including Portion Attributable To Noncontrolling Interest us-gaap/2024 0 0 monetary I C Equity, Including Portion Attributable to Noncontrolling Interest Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.
Comprehensive Income Net Of Tax us-gaap/2024 0 0 monetary D C Comprehensive Income (Loss), Net of Tax, Attributable to Parent Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest us-gaap/2024 0 0 monetary D D Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest us-gaap/2024 0 0 monetary D C Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.
Liabilities us-gaap/2024 0 0 monetary I C Liabilities Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.
Liabilities And Stockholders Equity us-gaap/2024 0 0 monetary I C Liabilities and Equity Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Net Income Loss Attributable To Noncontrolling Interest us-gaap/2024 0 0 monetary D D Net Income (Loss) Attributable to Noncontrolling Interest Amount of Net Income (Loss) attributable to noncontrolling interest.
Payments Of Dividends us-gaap/2024 0 0 monetary D C Payments of Dividends Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.
Payments To Acquire Productive Assets us-gaap/2024 0 0 monetary D C Payments to Acquire Productive Assets The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.
Retained Earnings Accumulated Deficit us-gaap/2024 0 0 monetary I C Retained Earnings (Accumulated Deficit) Amount of accumulated undistributed earnings (deficit).
Additional Paid In Capital us-gaap/2024 0 0 monetary I C Additional Paid in Capital Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.
Common Stock Dividends Per Share Declared us-gaap/2024 0 0 perShare D Common Stock, Dividends, Per Share, Declared Aggregate dividends declared during the period for each share of common stock outstanding.
Common Stock Par Or Stated Value Per Share us-gaap/2024 0 0 perShare I Common Stock, Par or Stated Value Per Share Face amount or stated value per share of common stock.
Common Stock Shares Outstanding us-gaap/2024 0 0 shares I Common Stock, Shares, Outstanding Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Debt Current us-gaap/2024 0 0 monetary I C Debt, Current Amount of debt and lease obligation, classified as current.
Income Tax Expense Benefit us-gaap/2024 0 0 monetary D D Income Tax Expense (Benefit) Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Net Income Loss us-gaap/2024 0 0 monetary D C Net Income (Loss) Attributable to Parent The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Payments For Hedge Investing Activities us-gaap/2024 0 0 monetary D C Payments for Hedge, Investing Activities The cash outflow for a financial contract that meets the hedge criteria as either a cash flow hedge, fair value hedge, or hedge of a net investment in a foreign operation.
Stockholders Equity us-gaap/2024 0 0 monetary I C Equity, Attributable to Parent Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.
Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures us-gaap/2024 0 0 monetary D C Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.
Weighted Average Number Of Diluted Shares Outstanding us-gaap/2024 0 0 shares D Weighted Average Number of Shares Outstanding, Diluted The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Accumulated Other Comprehensive Income Loss Net Of Tax us-gaap/2024 0 0 monetary I C Accumulated Other Comprehensive Income (Loss), Net of Tax Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.
Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition us-gaap/2024 0 0 monetary D C APIC, Share-Based Payment Arrangement, ESPP, Increase for Cost Recognition Amount of increase in additional paid-in capital (APIC) for recognition of cost for employee stock purchase program (ESPP) award under share-based payment arrangement.
Assets us-gaap/2024 0 0 monetary I D Assets Amount of asset recognized for present right to economic benefit.
Common Stock Shares Issued us-gaap/2024 0 0 shares I Common Stock, Shares, Issued Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Cost Of Goods And Services Sold us-gaap/2024 0 0 monetary D D Cost of Goods and Services Sold The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.
Earnings Per Share Diluted us-gaap/2024 0 0 perShare D Earnings Per Share, Diluted The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 0 0 monetary D D Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Gross Profit us-gaap/2024 0 0 monetary D C Gross Profit Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.
Operating Lease Right Of Use Asset us-gaap/2024 0 0 monetary I D Operating Lease, Right-of-Use Asset Amount of lessee's right to use underlying asset under operating lease.
Other Assets Noncurrent us-gaap/2024 0 0 monetary I D Other Assets, Noncurrent Amount of noncurrent assets classified as other.
Accrued Liabilities Current us-gaap/2024 0 0 monetary I C Accrued Liabilities, Current Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Fair Value Of Assets Acquired us-gaap/2024 0 0 monetary D D Fair Value of Assets Acquired The fair value of assets acquired in noncash investing or financing activities.
Increase Decrease In Accrued Income Taxes Payable us-gaap/2024 0 0 monetary D D Increase (Decrease) in Income Taxes Payable The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.
Interest Expense Nonoperating us-gaap/2024 0 0 monetary D D Interest Expense, Nonoperating Amount of interest expense classified as nonoperating.
Liabilities Current us-gaap/2024 0 0 monetary I C Liabilities, Current Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Other Comprehensive Income Loss Net Of Tax us-gaap/2024 0 0 monetary D C Other Comprehensive Income (Loss), Net of Tax Amount after tax and reclassification adjustments of other comprehensive income (loss).
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax us-gaap/2024 0 0 monetary D C Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.
Preferred Stock Shares Issued us-gaap/2024 0 0 shares I Preferred Stock, Shares Issued Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.
Repayments Of Long Term Debt us-gaap/2024 0 0 monetary D C Repayments of Long-Term Debt The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.
Restructuring Charges us-gaap/2024 0 0 monetary D D Restructuring Charges Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.
Selling General And Administrative Expense us-gaap/2024 0 0 monetary D D Selling, General and Administrative Expense The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.
Share Based Compensation us-gaap/2024 0 0 monetary D D Share-Based Payment Arrangement, Noncash Expense Amount of noncash expense for share-based payment arrangement.
Cash And Cash Equivalents At Carrying Value us-gaap/2024 0 0 monetary I D Cash and Cash Equivalents, at Carrying Value Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
Increase Decrease In Inventories us-gaap/2024 0 0 monetary D C Increase (Decrease) in Inventories The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.
Increase Decrease In Prepaid Deferred Expense And Other Assets us-gaap/2024 0 0 monetary D C Increase (Decrease) in Prepaid Expense and Other Assets Amount of increase (decrease) in prepaid expenses, and assets classified as other.
Other Noncash Income Expense us-gaap/2024 0 0 monetary D C Other Noncash Income (Expense) Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.
Preferred Stock Value us-gaap/2024 0 0 monetary I C Preferred Stock, Value, Issued Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.
Proceeds From Repayments Of Short Term Debt Maturing In More Than Three Months us-gaap/2024 0 0 monetary D D Proceeds from (Repayments of) Short-Term Debt, Maturing in More than Three Months The cash inflow from a borrowing net of the cash outflow from repayment of a borrowing having initial term of repayment of more than three months but less than one year or one operating cycle (if the normal cycle is more than one year).
Proceeds From Sale Of Property Plant And Equipment us-gaap/2024 0 0 monetary D D Proceeds from Sale of Property, Plant, and Equipment The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.
Profit Loss us-gaap/2024 0 0 monetary D C Net Income (Loss), Including Portion Attributable to Noncontrolling Interest The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.
Capital Expenditures Incurred But Not Yet Paid us-gaap/2024 0 0 monetary D C Capital Expenditures Incurred but Not yet Paid Future cash outflow to pay for purchases of fixed assets that have occurred.
Accrued Income Taxes Current us-gaap/2024 0 0 monetary I C Accrued Income Taxes, Current Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.
Deferred Income Tax Expense Benefit us-gaap/2024 0 0 monetary D D Deferred Income Tax Expense (Benefit) Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Goodwill us-gaap/2024 0 0 monetary I D Goodwill Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.
Impairment Of Intangible Assets Indefinitelived Excluding Goodwill us-gaap/2024 0 0 monetary D D Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill) Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.
Intangible Assets Net Excluding Goodwill us-gaap/2024 0 0 monetary I D Intangible Assets, Net (Excluding Goodwill) Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.
Net Cash Provided By Used In Operating Activities us-gaap/2024 0 0 monetary D Net Cash Provided by (Used in) Operating Activities Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Operating Income Loss us-gaap/2024 0 0 monetary D C Operating Income (Loss) The net result for the period of deducting operating expenses from operating revenues.
Other Liabilities Noncurrent us-gaap/2024 0 0 monetary I C Other Liabilities, Noncurrent Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.
Prepaid Expense And Other Assets Current us-gaap/2024 0 0 monetary I D Prepaid Expense and Other Assets, Current Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.
Proceeds From Derivative Instrument Investing Activities us-gaap/2024 0 0 monetary D D Proceeds from Derivative Instrument, Investing Activities The cash inflow provided by derivative instruments during the period, which are classified as investing activities, excluding those designated as hedging instruments.
Proceeds From Other Short Term Debt us-gaap/2024 0 0 monetary D D Proceeds from Other Short-Term Debt Amount of cash inflow from short-term debt classified as other.
Proceeds From Payments For Other Financing Activities us-gaap/2024 0 0 monetary D D Proceeds from (Payments for) Other Financing Activities Amount of cash inflow (outflow) from financing activities classified as other.
Common Stock Value us-gaap/2024 0 0 monetary I C Common Stock, Value, Issued Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
Inventory Net us-gaap/2024 0 0 monetary I D Inventory, Net Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.
Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization us-gaap/2024 0 0 monetary I D Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.
Research And Development Expense us-gaap/2024 0 0 monetary D D Research and Development Expense Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.
Accounts Payable Current us-gaap/2024 0 0 monetary I C Accounts Payable, Current Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect us-gaap/2024 0 0 monetary D D Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Amortization Of Intangible Assets us-gaap/2024 0 0 monetary D D Amortization of Intangible Assets The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Commitments And Contingencies us-gaap/2024 0 0 monetary I C Commitments and Contingencies Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.
Common Stock Shares Authorized us-gaap/2024 0 0 shares I Common Stock, Shares Authorized The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Deferred Income Tax Liabilities Net us-gaap/2024 0 0 monetary I C Deferred Income Tax Liabilities, Net Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.
Preferred Stock Par Or Stated Value Per Share us-gaap/2024 0 0 perShare I Preferred Stock, Par or Stated Value Per Share Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.
Dividends Cash us-gaap/2024 0 0 monetary D D Dividends, Cash Amount of paid and unpaid cash dividends declared for classes of stock, for example, but not limited to, common and preferred.
Increase Decrease In Accounts Payable us-gaap/2024 0 0 monetary D D Increase (Decrease) in Accounts Payable The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.
Interest Paid Net us-gaap/2024 0 0 monetary D C Interest Paid, Excluding Capitalized Interest, Operating Activities Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
Net Cash Provided By Used In Financing Activities us-gaap/2024 0 0 monetary D D Net Cash Provided by (Used in) Financing Activities Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Net Cash Provided By Used In Investing Activities us-gaap/2024 0 0 monetary D D Net Cash Provided by (Used in) Investing Activities Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value us-gaap/2024 0 0 monetary D C APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.
Depreciation us-gaap/2024 0 0 monetary D D Depreciation The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Earnings Per Share Basic us-gaap/2024 0 0 perShare D Earnings Per Share, Basic The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Payments Of Financing Costs us-gaap/2024 0 0 monetary D C Payments of Financing Costs The cash outflow for loan and debt issuance costs.
Other Nonoperating Income Expense us-gaap/2024 0 0 monetary D C Other Nonoperating Income (Expense) Amount of income (expense) related to nonoperating activities, classified as other.
Preferred Stock Shares Authorized us-gaap/2024 0 0 shares I Preferred Stock, Shares Authorized The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
Treasury Stock Common Value us-gaap/2024 0 0 monetary I D Treasury Stock, Common, Value Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.
Accounts Notes And Loans Receivable Net Current us-gaap/2024 0 0 monetary I D Accounts and Financing Receivable, after Allowance for Credit Loss, Current Amount, after allowance for credit loss, of accounts and financing receivables, classified as current. Includes, but is not limited to, notes and loan receivable.
Increase Decrease In Accounts And Notes Receivable us-gaap/2024 0 0 monetary D C Increase (Decrease) in Accounts and Notes Receivable The increase (decrease) during the reporting period of the sum of amounts due within one year (or one business cycle) from customers for the credit sale of goods and services; and from note holders for outstanding loans.
Increase Decrease In Accrued Liabilities us-gaap/2024 0 0 monetary D D Increase (Decrease) in Accrued Liabilities The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.
Increase Decrease In Other Noncurrent Liabilities us-gaap/2024 0 0 monetary D D Increase (Decrease) in Other Noncurrent Liabilities Amount of increase (decrease) in noncurrent operating liabilities classified as other.
Long Term Debt Noncurrent us-gaap/2024 0 0 monetary I C Long-Term Debt, Excluding Current Maturities Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.
Minority Interest us-gaap/2024 0 0 monetary I C Equity, Attributable to Noncontrolling Interest Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity.
Operating Lease Liability Noncurrent us-gaap/2024 0 0 monetary I C Operating Lease, Liability, Noncurrent Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.
Treasury Stock Common Shares us-gaap/2024 0 0 shares I Treasury Stock, Common, Shares Number of previously issued common shares repurchased by the issuing entity and held in treasury.
Weighted Average Number Of Shares Outstanding Basic us-gaap/2024 0 0 shares D Weighted Average Number of Shares Outstanding, Basic Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.

Description
Field Name Field Description
tag The unique identifier (name) for a tag in a specific taxonomy release.
version For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined.
custom 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns.
abstract 1 if the tag is not used to represent a numeric fact.
datatype If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag.
iord If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration.
crdr If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL.
tlabel If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here.
doc The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL.

Presentation of Statements

adsh report line stmt inpth rfile tag version plabel negating
0000818479-25-000056 2 1 IS 0 H Revenue From Contract With Customer Excluding Assessed Tax us-gaap/2024 Net sales 0
0000818479-25-000056 2 2 IS 0 H Cost Of Goods And Services Sold us-gaap/2024 Cost of products sold 0
0000818479-25-000056 2 3 IS 0 H Gross Profit us-gaap/2024 Gross profit 0
0000818479-25-000056 2 4 IS 0 H Selling General And Administrative Expense us-gaap/2024 Selling, general, and administrative expenses 0
0000818479-25-000056 2 5 IS 0 H Research And Development Expense us-gaap/2024 Research and development expenses 0
0000818479-25-000056 2 6 IS 0 H Impairment Of Intangible Assets Indefinitelived Excluding Goodwill us-gaap/2024 Intangible asset impairments 0
0000818479-25-000056 2 7 IS 0 H Restructuring Charges us-gaap/2024 Restructuring and other costs 0
0000818479-25-000056 2 8 IS 0 H Operating Income Loss us-gaap/2024 Operating income 0
0000818479-25-000056 2 10 IS 0 H Interest Expense Nonoperating us-gaap/2024 Interest expense, net 0
0000818479-25-000056 2 11 IS 0 H Other Nonoperating Income Expense us-gaap/2024 Other (income) expense, net 1
0000818479-25-000056 2 12 IS 0 H Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest us-gaap/2024 Income before income taxes 0
0000818479-25-000056 2 13 IS 0 H Income Tax Expense Benefit us-gaap/2024 Provision for income taxes 0
0000818479-25-000056 2 14 IS 0 H Profit Loss us-gaap/2024 Net income 0
0000818479-25-000056 2 15 IS 0 H Net Income Loss Attributable To Noncontrolling Interest us-gaap/2024 Less: Net loss attributable to noncontrolling interests 0
0000818479-25-000056 2 16 IS 0 H Net Income Loss us-gaap/2024 Net income attributable to Dentsply Sirona 0
0000818479-25-000056 2 18 IS 0 H Earnings Per Share Basic us-gaap/2024 Basic (in dollars per share) 0
0000818479-25-000056 2 19 IS 0 H Earnings Per Share Diluted us-gaap/2024 Diluted (in dollars per share) 0
0000818479-25-000056 2 21 IS 0 H Weighted Average Number Of Shares Outstanding Basic us-gaap/2024 Basic (in shares) 0
0000818479-25-000056 2 22 IS 0 H Weighted Average Number Of Diluted Shares Outstanding us-gaap/2024 Diluted (in shares) 0
0000818479-25-000056 3 1 CI 0 H Profit Loss us-gaap/2024 Net income 0
0000818479-25-000056 3 3 CI 0 H Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax us-gaap/2024 Foreign currency translation gain (loss) 0
0000818479-25-000056 3 4 CI 0 H Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax us-gaap/2024 Net (loss) gain on derivative financial instruments 0
0000818479-25-000056 3 5 CI 0 H Other Comprehensive Income Loss Net Of Tax us-gaap/2024 Total other comprehensive income (loss), net of tax 0
0000818479-25-000056 3 6 CI 0 H Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest us-gaap/2024 Total comprehensive income (loss) 0
0000818479-25-000056 3 7 CI 0 H Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest us-gaap/2024 Less: Comprehensive loss attributable to noncontrolling interests 0
0000818479-25-000056 3 8 CI 0 H Comprehensive Income Net Of Tax us-gaap/2024 Total comprehensive income (loss) attributable to Dentsply Sirona 0
0000818479-25-000056 4 3 BS 0 H Cash And Cash Equivalents At Carrying Value us-gaap/2024 Cash and cash equivalents 0
0000818479-25-000056 4 4 BS 0 H Accounts Notes And Loans Receivable Net Current us-gaap/2024 Accounts and notes receivable-trade, net 0
0000818479-25-000056 4 5 BS 0 H Inventory Net us-gaap/2024 Inventories, net 0
0000818479-25-000056 4 6 BS 0 H Prepaid Expense And Other Assets Current us-gaap/2024 Prepaid expenses and other current assets 0
0000818479-25-000056 4 7 BS 0 H Assets Current us-gaap/2024 Total Current Assets 0
0000818479-25-000056 4 8 BS 0 H Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization us-gaap/2024 Property, plant, and equipment, net 0
0000818479-25-000056 4 9 BS 0 H Operating Lease Right Of Use Asset us-gaap/2024 Operating lease right-of-use assets, net 0
0000818479-25-000056 4 10 BS 0 H Intangible Assets Net Excluding Goodwill us-gaap/2024 Identifiable intangible assets, net 0
0000818479-25-000056 4 11 BS 0 H Goodwill us-gaap/2024 Goodwill 0
0000818479-25-000056 4 12 BS 0 H Other Assets Noncurrent us-gaap/2024 Other noncurrent assets 0
0000818479-25-000056 4 13 BS 0 H Assets us-gaap/2024 Total Assets 0
0000818479-25-000056 4 16 BS 0 H Accounts Payable Current us-gaap/2024 Accounts payable 0
0000818479-25-000056 4 17 BS 0 H Accrued Liabilities Current us-gaap/2024 Accrued liabilities 0
0000818479-25-000056 4 18 BS 0 H Accrued Income Taxes Current us-gaap/2024 Income taxes payable 0
0000818479-25-000056 4 19 BS 0 H Debt Current us-gaap/2024 Notes payable and current portion of long-term debt 0
0000818479-25-000056 4 20 BS 0 H Liabilities Current us-gaap/2024 Total Current Liabilities 0
0000818479-25-000056 4 21 BS 0 H Long Term Debt Noncurrent us-gaap/2024 Long-term debt 0
0000818479-25-000056 4 22 BS 0 H Operating Lease Liability Noncurrent us-gaap/2024 Operating lease liabilities 0
0000818479-25-000056 4 23 BS 0 H Deferred Income Tax Liabilities Net us-gaap/2024 Deferred income taxes 0
0000818479-25-000056 4 24 BS 0 H Other Liabilities Noncurrent us-gaap/2024 Other noncurrent liabilities 0
0000818479-25-000056 4 25 BS 0 H Liabilities us-gaap/2024 Total Liabilities 0
0000818479-25-000056 4 26 BS 0 H Commitments And Contingencies us-gaap/2024 Commitments and contingencies (Note 14) 0
0000818479-25-000056 4 28 BS 0 H Preferred Stock Value us-gaap/2024 Preferred stock, $1.00 par value; 0.25 million shares authorized; no shares issued 0
0000818479-25-000056 4 29 BS 0 H Common Stock Value us-gaap/2024 Common stock, $0.01 par value; 400.0 million shares authorized, and 264.5 million shares issued at March 31, 2025 and December 31, 2024 and December 31, 2023, 198.8 million and 207.2 million shares outstanding at March 31, 2025 and December 31, 2024 0
0000818479-25-000056 4 30 BS 0 H Additional Paid In Capital us-gaap/2024 Capital in excess of par value 0
0000818479-25-000056 4 31 BS 0 H Retained Earnings Accumulated Deficit us-gaap/2024 Accumulated deficit 0
0000818479-25-000056 4 32 BS 0 H Accumulated Other Comprehensive Income Loss Net Of Tax us-gaap/2024 Accumulated other comprehensive loss 0
0000818479-25-000056 4 33 BS 0 H Treasury Stock Common Value us-gaap/2024 Treasury stock, at cost, 65.2 million and 65.7 million shares at March 31, 2025 and December 31, 2024, respectively 1
0000818479-25-000056 4 34 BS 0 H Stockholders Equity us-gaap/2024 Total Dentsply Sirona Equity 0
0000818479-25-000056 4 35 BS 0 H Minority Interest us-gaap/2024 Noncontrolling interests 0
0000818479-25-000056 4 36 BS 0 H Stockholders Equity Including Portion Attributable To Noncontrolling Interest us-gaap/2024 Total Equity 0
0000818479-25-000056 4 37 BS 0 H Liabilities And Stockholders Equity us-gaap/2024 Total Liabilities and Equity 0
0000818479-25-000056 5 2 BS 1 H Preferred Stock Par Or Stated Value Per Share us-gaap/2024 Preferred stock, par value (in dollars per share) 0
0000818479-25-000056 5 3 BS 1 H Preferred Stock Shares Authorized us-gaap/2024 Preferred stock, shares authorized (in shares) 0
0000818479-25-000056 5 4 BS 1 H Preferred Stock Shares Issued us-gaap/2024 Preferred stock, shares issued (in shares) 0
0000818479-25-000056 5 5 BS 1 H Common Stock Par Or Stated Value Per Share us-gaap/2024 Common stock, par value (in dollars per share) 0
0000818479-25-000056 5 6 BS 1 H Common Stock Shares Authorized us-gaap/2024 Common stock, shares authorized (in shares) 0
0000818479-25-000056 5 7 BS 1 H Common Stock Shares Issued us-gaap/2024 Common stock, shares issued (in shares) 0
0000818479-25-000056 5 8 BS 1 H Common Stock Shares Outstanding us-gaap/2024 Common stock, shares outstanding (in shares) 0
0000818479-25-000056 5 9 BS 1 H Treasury Stock Common Shares us-gaap/2024 Treasury stock, shares (in shares) 0
0000818479-25-000056 6 13 EQ 0 H Stockholders Equity Including Portion Attributable To Noncontrolling Interest us-gaap/2024 Beginning Balance 0
0000818479-25-000056 6 14 EQ 0 H Profit Loss us-gaap/2024 Net income (loss) 0
0000818479-25-000056 6 15 EQ 0 H Other Comprehensive Income Loss Net Of Tax us-gaap/2024 Other comprehensive (loss) income 0
0000818479-25-000056 6 16 EQ 0 H Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value us-gaap/2024 Stock-based compensation expense 0
0000818479-25-000056 6 17 EQ 0 H Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition us-gaap/2024 Funding of employee stock purchase plan 0
0000818479-25-000056 6 18 EQ 0 H Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures us-gaap/2024 Restricted stock unit distributions 0
0000818479-25-000056 6 19 EQ 0 H Dividends Share Based Compensation Cash us-gaap/2024 Restricted stock unit dividends 1
0000818479-25-000056 6 20 EQ 0 H Dividends Cash us-gaap/2024 Cash dividends 1
0000818479-25-000056 6 21 EQ 0 H Stockholders Equity Including Portion Attributable To Noncontrolling Interest us-gaap/2024 Ending Balance 0
0000818479-25-000056 7 1 EQ 1 H Common Stock Dividends Per Share Declared us-gaap/2024 Cash dividends (in dollars per share) 0
0000818479-25-000056 8 2 CF 0 H Profit Loss us-gaap/2024 Net income 0
0000818479-25-000056 8 4 CF 0 H Depreciation us-gaap/2024 Depreciation 0
0000818479-25-000056 8 5 CF 0 H Amortization Of Intangible Assets us-gaap/2024 Amortization of intangible assets 0
0000818479-25-000056 8 6 CF 0 H Impairment Of Intangible Assets Indefinitelived Excluding Goodwill us-gaap/2024 Indefinite-lived intangible asset impairment 0
0000818479-25-000056 8 7 CF 0 H Deferred Income Tax Expense Benefit us-gaap/2024 Deferred income taxes 0
0000818479-25-000056 8 8 CF 0 H Share Based Compensation us-gaap/2024 Stock-based compensation expense 0
0000818479-25-000056 8 9 CF 0 H Other Noncash Income Expense us-gaap/2024 Other non-cash expense 1
0000818479-25-000056 8 11 CF 0 H Increase Decrease In Accounts And Notes Receivable us-gaap/2024 Accounts and notes receivable-trade, net 1
0000818479-25-000056 8 12 CF 0 H Increase Decrease In Inventories us-gaap/2024 Inventories, net 1
0000818479-25-000056 8 13 CF 0 H Increase Decrease In Prepaid Deferred Expense And Other Assets us-gaap/2024 Prepaid expenses and other current assets 1
0000818479-25-000056 8 14 CF 0 H Increase Decrease In Other Noncurrent Assets us-gaap/2024 Other noncurrent assets 1
0000818479-25-000056 8 15 CF 0 H Increase Decrease In Accounts Payable us-gaap/2024 Accounts payable 0
0000818479-25-000056 8 16 CF 0 H Increase Decrease In Accrued Liabilities us-gaap/2024 Accrued liabilities 0
0000818479-25-000056 8 17 CF 0 H Increase Decrease In Accrued Income Taxes Payable us-gaap/2024 Income taxes 0
0000818479-25-000056 8 18 CF 0 H Increase Decrease In Other Noncurrent Liabilities us-gaap/2024 Other noncurrent liabilities 0
0000818479-25-000056 8 19 CF 0 H Net Cash Provided By Used In Operating Activities us-gaap/2024 Net cash provided by operating activities 0
0000818479-25-000056 8 21 CF 0 H Payments To Acquire Productive Assets us-gaap/2024 Capital expenditures 1
0000818479-25-000056 8 22 CF 0 H Proceeds From Derivative Instrument Investing Activities us-gaap/2024 Cash received on derivative contracts 0
0000818479-25-000056 8 23 CF 0 H Payments For Hedge Investing Activities us-gaap/2024 Cash paid on derivative contracts 1
0000818479-25-000056 8 24 CF 0 H Proceeds From Sale Of Property Plant And Equipment us-gaap/2024 Proceeds from sale of property, plant, and equipment 0
0000818479-25-000056 8 25 CF 0 H Net Cash Provided By Used In Investing Activities us-gaap/2024 Net cash used in investing activities 0
0000818479-25-000056 8 27 CF 0 H Proceeds From Repayments Of Short Term Debt Maturing In More Than Three Months us-gaap/2024 (Repayments) proceeds on short-term borrowings, net 0
0000818479-25-000056 8 28 CF 0 H Proceeds From Other Short Term Debt us-gaap/2024 Proceeds from 364-day bridge loan 0
0000818479-25-000056 8 29 CF 0 H Payments Of Dividends us-gaap/2024 Cash dividends paid 1
0000818479-25-000056 8 30 CF 0 H Repayments Of Long Term Debt us-gaap/2024 Repayments on long-term borrowings 1
0000818479-25-000056 8 31 CF 0 H Payments Of Financing Costs us-gaap/2024 Cash paid for deferred financing costs 1
0000818479-25-000056 8 32 CF 0 H Proceeds From Payments For Other Financing Activities us-gaap/2024 Other financing activities, net 0
0000818479-25-000056 8 33 CF 0 H Net Cash Provided By Used In Financing Activities us-gaap/2024 Net cash provided by (used in) financing activities 0
0000818479-25-000056 8 34 CF 0 H Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 Effect of exchange rate changes on cash and cash equivalents 0
0000818479-25-000056 8 35 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect us-gaap/2024 Net increase (decrease) in cash and cash equivalents 0
0000818479-25-000056 8 36 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 Cash and cash equivalents at beginning of period 0
0000818479-25-000056 8 37 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 Cash and cash equivalents at end of period 0
0000818479-25-000056 8 39 CF 0 H Interest Paid Net us-gaap/2024 Interest paid, net of amounts capitalized 0
0000818479-25-000056 8 41 CF 0 H Capital Expenditures Incurred But Not Yet Paid us-gaap/2024 Property, plant and equipment in accounts payable at end of period 0
0000818479-25-000056 8 42 CF 0 H Fair Value Of Assets Acquired us-gaap/2024 Exchange of inventory for naming and other rights 0

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
report Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site.
line Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived.
stmt The financial statement location to which the value of the “report” field pertains.
inpth Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700.
rfile The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file.
tag The tag chosen by the filer for this line item.
version The taxonomy identifier if the tag is a standard tag, otherwise adsh.
plabel The text presented on the line item, also known as a “preferred” label.
negating Flag to indicate whether the plabel is negating.